| |
Rouet ,V, Meddahi-Pellé A, Miao Hua-Quan , Vlodavsky I , Caruelle J. P , Barritault D
Heparin-like synthetic polymers, named RGTAs, mimic biological effects of heparin in vitro. J. Bio Mater. Res. Published Online: 1 Jun 2006
*Corinne Lallam-Laroye, Quentin Escartin, Aude-Sophie Zlowodzki, Denis
Barritault, Jean-Pierre Caruelle, Brigitte Baroukh, Jean-Louis Saffar,
and Marie-Laure Colombier. Periodontitis destructions are restored by
synthetic glycosaminoglycan mimetic J. Bio Mater. Res. 2006 79A,675-83.
*Garcia-Filipe S, Barbier-Chassefiere V, Alexakis C, Huet C, Ledoux D,
Kerros ME, Petit E, Barritault D, Caruelle JP*, Kern P. RGTA OTR4120, a
heparan sulfate mimetic is a possible long-term active agent to heal
burned skin.” J. Bio Mater. Res. On line and 80A 75-84, 2007.
Barritault D, Caruelle JP. Regenerating agents (RGTAs): a new therapeutic approach
Ann Pharm Fr. 2006 Mar;64(2):135-44. Review. French.
*Rouet V, Hamma-Kourbali Y, Petit E, Panagopoulou P, Katsoris P, Barritault
D, Caruelle JP, Courty J. A synthetic glycosaminoglycan mimetic binds
vascular endothelial growth factor and modulates angiogenesis.J Biol Chem. 2005 Jul 13.
Barbosa I, Morin C, Garcia S, Duchesnay A, Oudghir M, Jenniskens G,
Miao HQ, Guimond S, Carpentier G, Cebrian J, Caruelle JP, van Kuppevelt
T, Turnbull J, Martelly I, Papy-Garcia D. “A synthetic
glycosaminoglycan mimetic (RGTA) modifies natural glycosaminoglycan
species during myogenesis” J Cell Sci. 2005 Jan 1; 118(Pt 1):253-64.
*Alexakis C, Caruelle JP, Sezeur A, Cosnes J, Gendre JP, Mosnier H,
Beaugerie L, Gallot D, Malafosse M, Barritault D, Kern P. “Reversal of
abnormal collagen production in Crohn's disease intestinal biopsies
treated with regenerating agents”. Gut. 2004 Jan; 53(1):85-90.
*Alexakis C, Mestries P, Garcia S, Petit E, Barbier V, Papy-Garcia D,
Sagot MA, Barritault D, Caruelle JP, Kern P. “Structurally different
RGTAs modulate collagen-type expression by cultured aortic smooth
muscle cells via different pathways involving fibroblast growth
factor-2 or transforming growth factor-beta1”. FASEB J. 2004 Jul; 18(10):1147-9. Epub 2004 May 7.
*Morvan FO, Baroukh B, Ledoux D, Caruelle JP, Barritault D, Godeau G,
Saffar JL. “An engineered biopolymer prevents mucositis induced by
5-fluorouracil in hamsters”. Am J Pathol. 2004 Feb; 164(2):739-46.
*Escartin Q, Lallam-Laroye C, Baroukh B, Morvan FO, Caruelle JP, Godeau
G, Barritault D, Saffar JL. “A new approach to treat tissue destruction
in periodontitis with chemically modified dextran polymers”. FASEB J. 2003 Apr; 17(6):644-51.
Meddahi A, Alexakis C, Papy D, Caruelle JP, Barritault D. “Heparin-like
polymer improved healing of gastric and colic ulceration”. J Biomed Mater Res. 2002 Jun 5; 60(3):497-501.
Meddahi A, Bree F, Papy-Garcia D, Gautron J, Barritault D, Caruelle JP.
“Pharmacological studies of RGTA(11), a heparan sulfate mimetic
polymer, efficient on muscle regeneration”. J Biomed Mater Res. 2002 Dec 15; 62(4):525-31.
*Alexakis C, Guettoufi A, Mestries P, Strup C, Mathe D, Barbaud C,
Barritault D, Caruelle JP, Kern P. “Heparan mimetic regulates collagen
expression and TGF-beta1 distribution in gamma-irradiated human
intestinal smooth muscle cells”. FASEB J. 2001 Jul; 15(9):1546-54.
* Ledoux D, Papy-Garcia D, Escartin Q, Sagot MA, Cao Y, Barritault D,
Courtois J, Hornebeck W, Caruelle JP. “Human plasmin enzymatic activity
is inhibited by chemically modified dextrans”. J Biol Chem. 2000 Sep 22; 275(38):29383-90.
*Yamauchi H, Desgranges P, Lecerf L, Papy-Garcia D, Tournaire MC,
Moczar M, Loisance D, Barritault D. “New agents for the treatment of
infarcted myocardium”. FASEB J. 2000 (14): 2133-4.
*Desgranges P, Barbaud C, Caruelle JP, Barritault D, Gautron J. “A
substituted dextran enhances muscle fiber survival and regeneration in
ischemic and denervated rat EDL muscle”. FASEB J. 1999 Apr; 13(6):761-6.
*Albo D, Long C, Jhala N, Atkinson B, Granick MS, Wang T, Meddahi A,
Barritault D, Solomon MP. “Modulation of cranial bone healing with a
heparin-like dextran derivative”. J Craniofac Surg. 1996 Jan; 7(1):19-22.
Aamiri A, Butler-Browne GS, Martelly I, Barritault D, Gautron J.
“Influence of a dextran derivative on myosin heavy chain expression
during rat skeletal muscle regeneration”. Neurosci Lett. 1995 Dec 15; 201(3):243-6.
*Blanquaert F, Saffar JL, Colombier ML, Carpentier G, Barritault D,
Caruelle JP “Heparan-like molecules induce the repair of skull
defects”. Bone. 1995 Dec; 17(6):499-506.
*Aamiri A, Mobarek A, Carpentier G, Barritault D, Gautron J. “Effects
of substituted dextran on reinnervation of a skeletal muscle in adult
rats during regeneration” C R Acad Sci III. 1995 Oct; 318(10):1037-43. French.
*Gautron J, Kedzia C, Husmann I, Barritault D. “Acceleration of the
regeneration of skeletal muscles in adult rats by dextran derivatives” C R Acad Sci III. 1995 Jun; 318(6):671-6. French.
|